Literature DB >> 20170930

Presence or absence of a known diabetic ketoacidosis precipitant defines distinct syndromes of "A-β+" ketosis-prone diabetes based on long-term β-cell function, human leukocyte antigen class II alleles, and sex predilection.

Ramaswami Nalini1, Kerem Ozer, Mario Maldonado, Sanjeet G Patel, Christiane S Hampe, Anu Guthikonda, Jesus Villanueva, E O'Brian Smith, Lakshmi K Gaur, Ashok Balasubramanyam.   

Abstract

Ketosis-prone diabetes (KPD) is heterogeneous. Longitudinal follow-up revealed that patients with "A-β+" KPD (absent autoantibodies and preserved β-cell function) segregated into 2 subgroups with distinct evolution of β-cell function and glycemic control. Generalized linear analysis demonstrated that the variable that most significantly differentiated them was presence of a clinically evident precipitating event for the index diabetic ketoacidosis (DKA). Hence, we performed a comprehensive analysis of A-β+ KPD patients presenting with "provoked" compared with "unprovoked" DKA. Clinical, biochemical, and β-cell functional characteristics were compared between provoked and unprovoked A-β+ KPD patients followed prospectively for 1 to 8 years. Human leukocyte antigen class II allele frequencies were compared between these 2 groups and population controls. Unprovoked A-β+ KPD patients (n = 83) had greater body mass index, male preponderance, higher frequency of women with oligo-/anovulation, more frequent African American ethnicity, and less frequent family history of diabetes than provoked A-β+ KPD patients (n = 64). The provoked group had higher frequencies of the human leukocyte antigen class II type 1 diabetes mellitus susceptibility alleles DQB1*0302 (than the unprovoked group or population controls) and DRB1*04 (than the unprovoked group), whereas the unprovoked group had a higher frequency of the protective allele DQB1*0602. β-Cell secretory reserve and glycemic control improved progressively in the unprovoked group but declined in the provoked group. The differences persisted in comparisons restricted to patients with new-onset diabetes. "Unprovoked" A-β+ KPD is a distinct syndrome characterized by reversible β-cell dysfunction with male predominance and increased frequency of DQB1*0602, whereas "provoked" A-β+ KPD is characterized by progressive loss of β-cell reserve and increased frequency of DQB1*0302 and DRB1*04. Unprovoked DKA predicts long-term β-cell functional reserve, insulin independence, and glycemic control in KPD.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20170930      PMCID: PMC2888957          DOI: 10.1016/j.metabol.2010.01.009

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  21 in total

1.  Standards of medical care for patients with diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2003-01       Impact factor: 19.112

2.  ZnT8 autoantibody titers in type 1 diabetes patients decline rapidly after clinical onset.

Authors:  Fariba Vaziri-Sani; Shilpa Oak; Jared Radtke; Ke Lernmark; Kristian Lynch; Carl-D Agardh; Corrado M Cilio; Asa L Lethagen; Eva Ortqvist; Mona Landin-Olsson; Carina Törn; Christiane S Hampe
Journal:  Autoimmunity       Date:  2010-03-19       Impact factor: 2.815

Review 3.  Idiopathic Type 1 diabetes.

Authors:  A Piñero-Piloña; P Raskin
Journal:  J Diabetes Complications       Date:  2001 Nov-Dec       Impact factor: 2.852

4.  Ketoacidosis in Apache Indians with non-insulin-dependent diabetes mellitus.

Authors:  C Wilson; J Krakoff; D Gohdes
Journal:  Arch Intern Med       Date:  1997-10-13

5.  Characteristics of Caucasian type 2 diabetic patients during ketoacidosis and at follow-up.

Authors:  N Pitteloud; J Philippe
Journal:  Schweiz Med Wochenschr       Date:  2000-04-22

Review 6.  Diabetes in Africans. Part 2: Ketosis-prone atypical diabetes mellitus.

Authors:  E Sobngwi; F Mauvais-Jarvis; P Vexiau; J C Mbanya; J F Gautier
Journal:  Diabetes Metab       Date:  2002-02       Impact factor: 6.041

Review 7.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

Authors: 
Journal:  Hum Reprod       Date:  2004-01       Impact factor: 6.918

8.  GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes.

Authors:  M A Banerji; R L Chaiken; H Huey; T Tuomi; A J Norin; I R Mackay; M J Rowley; P Z Zimmet; H E Lebovitz
Journal:  Diabetes       Date:  1994-06       Impact factor: 9.461

9.  Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classification, prospective analysis, and clinical outcomes.

Authors:  Mario Maldonado; Christiane S Hampe; Lakshmi K Gaur; Susana D'Amico; Dinakar Iyer; Lisa P Hammerle; Douglas Bolgiano; Lucille Rodriguez; Arun Rajan; Ake Lernmark; Ashok Balasubramanyam
Journal:  J Clin Endocrinol Metab       Date:  2003-11       Impact factor: 5.958

10.  Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance.

Authors:  Franck Mauvais-Jarvis; Eugène Sobngwi; Raphaël Porcher; Jean-Pierre Riveline; Jean-Philippe Kevorkian; Christian Vaisse; Guillaume Charpentier; Pierre-Jean Guillausseau; Patrick Vexiau; Jean-François Gautier
Journal:  Diabetes       Date:  2004-03       Impact factor: 9.461

View more
  16 in total

1.  The villain with a thousand faces.

Authors:  Ashok Balasubramanyam
Journal:  J Diabetes Complications       Date:  2014-02-18       Impact factor: 2.852

2.  Masked and overt autoantibodies specific to the DPD epitope of 65-kDa glutamate decarboxylase (GAD65-DPD) are associated with preserved β-cell functional reserve in ketosis-prone diabetes.

Authors:  Shilpa Oak; Lakshmi K Gaur; Jared Radtke; Roshni Patel; Dinakar Iyer; Nalini Ram; Ruchi Gaba; Ashok Balasubramanyam; Christiane S Hampe
Journal:  J Clin Endocrinol Metab       Date:  2014-03-06       Impact factor: 5.958

Review 3.  DIABETIC KETOACIDOSIS: A COMMON DEBUT OF DIABETES AMONG AFRICAN AMERICANS WITH TYPE 2 DIABETES.

Authors:  Priyathama Vellanki; Guillermo E Umpierrez
Journal:  Endocr Pract       Date:  2017-05-23       Impact factor: 3.443

4.  Factors associated with early relapse to insulin dependence in unprovoked A-β+ ketosis-prone diabetes.

Authors:  Ruchi Gaba; Dhiraj Gambhire; Natalie Uy; Erica V Gonzalez; Dinakar Iyer; Christiane S Hampe; Nalini Ram; Ashok Balasubramanyam
Journal:  J Diabetes Complications       Date:  2015-04-30       Impact factor: 2.852

5.  Uncommon Presentations of Diabetes: Zebras in the Herd.

Authors:  Karen L Shidler; Lisa R Letourneau; Lucia M Novak
Journal:  Clin Diabetes       Date:  2020-01

6.  Pathogenesis of A⁻β⁺ ketosis-prone diabetes.

Authors:  Sanjeet G Patel; Jean W Hsu; Farook Jahoor; Ivonne Coraza; James R Bain; Robert D Stevens; Dinakar Iyer; Ramaswami Nalini; Kerem Ozer; Christiane S Hampe; Christopher B Newgard; Ashok Balasubramanyam
Journal:  Diabetes       Date:  2012-11-16       Impact factor: 9.461

7.  Ketosis-onset diabetes and ketosis-prone diabetes: same or not?

Authors:  Beiyan Liu; Changhua Yu; Qiang Li; Lin Li
Journal:  Int J Endocrinol       Date:  2013-04-23       Impact factor: 3.257

8.  HLA class II alleles susceptibility markers of type 1 diabetes fail to specify phenotypes of ketosis-prone diabetes in adult Tunisian patients.

Authors:  Lilia Laadhar; Fatma Harzallah; Mondher Zitouni; Maryam Kallel-Sellami; Moncef Fekih; Naziha Kaabachi; Hádia Slimane; Sondès Makni
Journal:  Exp Diabetes Res       Date:  2011-03-02

Review 9.  Toward an Improved Classification of Type 2 Diabetes: Lessons From Research into the Heterogeneity of a Complex Disease.

Authors:  Maria J Redondo; Ashok Balasubramanyam
Journal:  J Clin Endocrinol Metab       Date:  2021-11-19       Impact factor: 6.134

10.  Islet-specific T-cell responses and proinflammatory monocytes define subtypes of autoantibody-negative ketosis-prone diabetes.

Authors:  Barbara M Brooks-Worrell; Dinakar Iyer; Ivonne Coraza; Christiane S Hampe; Ramaswami Nalini; Kerem Ozer; Radhika Narla; Jerry P Palmer; Ashok Balasubramanyam
Journal:  Diabetes Care       Date:  2013-10-15       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.